Sudarshan Jain, Secretary General of Indian Pharmaceutical Alliance (IPA) with Anup Soans, Editor @ MedicinMan and IQVIA team of Amit Mookim, Managing Director, Swati Chaudhury, Director and Raj Sevilimedu, Principal at the launch of Sales View
- IMS Health is well known to pharma professionals all over the world, can you tell us more about your new identity, IQVIA? In what ways does it remain the same and what are new offerings?
Our clients have been instrumental in our becoming IQVIA. IMS Health and Quintiles came together because our clients were asking for better, faster ways to bring innovations to patients and capture the improvements the industry has been pursuing for years. Since the merger, we’ve worked to integrate our capabilities in advanced analytics, leading technologies and therapeutic expertise into powerful, differentiated offerings. Our vision is to outpace the inevitable progress of change across the life sciences and accelerate our ability to empower healthcare decision makers to meet the future head on.
Free Membership Required
You must be a Free member to access this content.
